DLB (Dualogics)

N/A

Report date: 2025/06/11 10:48:33

Base Information

Drug NameDLB (Dualogics)

Drug Alias Namebispecific monoclonal antibody (Dualogics)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionImmunostimulants

TargetsUpdating

Therapy Area/IndicationsTriple Negative Breast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesDualogics LLC

China Registration ClassN/A

Develop Information

Active CompaniesDualogics LLC

Inactive CompaniesN/A

Active IndicationsTriple Negative Breast Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A